Circulating T-cell subsets in Graves' disease: differences between patients with active disease and in remission after 131I-therapy

Clin Immunol Immunopathol. 1983 Aug;28(2):265-71. doi: 10.1016/0090-1229(83)90160-5.

Abstract

In the present investigation some surface markers in peripheral blood T lymphocytes of patients with active Graves' disease and subjects in remission after 131I-therapy have been studied. We confirmed low TG levels in untreated patients and normal values in treated subjects. Increased percentages of DR+, MLR4+ (activated T cells), and 5/9+ (inducer-helper) T cells were detected in patients with active disease, thus indicating the presence of activated T cells and suggesting increased levels of helper T cells. High percentages of MLR4+ and 5/9+, but normal levels of DR+ were found in 131I-treated subjects. The different distribution of DR and MLR4 positivities on 5/9+ and 5+9-T cells confirm the different meaning of these two markers of the activation state. The imbalance of T-cell subsets found in 131I-treated subjects and the normal values observed in patients with hyperthyroidism due to toxic adenoma indicate that hyperthyroidism per se is not sufficient to explain the T-cell alterations. The possible meaning of these findings is discussed with respect to previous hypotheses on the pathogenesis of Graves' disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / immunology
  • Female
  • Graves Disease / drug therapy
  • Graves Disease / immunology*
  • HLA-DR Antigens
  • Histocompatibility Antigens Class II / analysis
  • Humans
  • Iodine Radioisotopes / administration & dosage*
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Phenotype
  • Receptors, Fc / analysis
  • Receptors, IgG
  • Rosette Formation
  • T-Lymphocytes / classification*
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Monoclonal
  • HLA-DR Antigens
  • Histocompatibility Antigens Class II
  • Iodine Radioisotopes
  • Receptors, Fc
  • Receptors, IgG